Showing 1,041 - 1,060 results of 2,530 for search '"vaccines"', query time: 0.06s Refine Results
  1. 1041

    Protocol on establishing a prospective enhanced surveillance of vaccine preventable diseases in residential aged care facilities in Central Queensland, Australia: an observational study by Mohammad Rashidul Hashan, Robert Booy, Michael Kirk, Gulam Khandaker, Gwenda Chapman, Jacina Walker, Sonya Jayne Davidson, Jill Auriac, Nicolas Smoll, Delwar Akbar

    Published 2022-06-01
    “…Introduction Infectious diseases are a major cause of mortality and morbidity among the highly vulnerable occupants of residential aged care facilities (RACFs). The burden of vaccine preventable diseases (VPDs) among RACFs residents is mostly unknown and there is a lack of quality data from population-based prospective VPD surveillance in RACFs. …”
    Get full text
    Article
  2. 1042
  3. 1043

    A Dynamic Model of Information-Vaccination-Disease That Accounts for Emerging Viral Variants: Model Development and a Case Study for COVID-19 in Iceland by Laijun Zhao, Mingmin Ying, Ying Qian, Lixin Zhou, Pingle Yang

    Published 2024-01-01
    “…Pathogens mutate as diseases spread, and variants that become epidemic or pandemic strains have higher transmission rates and a greater capacity to escape vaccine protection. Considering different vaccine efficacy and vaccination rates is of great significance for the prevention and control of infectious diseases. …”
    Get full text
    Article
  4. 1044
  5. 1045

    Model for Vaccine Design by Prediction of B-Epitopes of IEDB Given Perturbations in Peptide Sequence, In Vivo Process, Experimental Techniques, and Source or Host Organisms by Humberto González-Díaz, Lázaro G. Pérez-Montoto, Florencio M. Ubeira

    Published 2014-01-01
    “…The model may be useful for the prediction of new epitopes or the optimization of known peptides towards computational vaccine design.…”
    Get full text
    Article
  6. 1046

    Herpes zoster vaccine and the risk of stroke: a population-based cohort study using linked data from the Clinical Practice Research Datalink by Fawziah Marra, Kathryn Richardson, Helen I McDonald, Yoon Kong Loke, Helen Mary Parretti

    Published 2024-04-01
    “…The active comparator comprised 653 373 adults receiving an influenza vaccination between 2013 and 2019 meeting herpes zoster vaccine eligibility. …”
    Get full text
    Article
  7. 1047

    An Attenuated Cytomegalovirus Vaccine with a Deletion of a Viral Chemokine Gene Is Protective against Congenital CMV Transmission in a Guinea Pig Model by Michael P. Leviton, Juan C. Lacayo, K. Yeon Choi, Nelmary Hernandez-Alvarado, Andrew Wey, Mark R. Schleiss

    Published 2013-01-01
    “…Development of a vaccine against congenital cytomegalovirus (CMV) infection is a public health priority, but CMVs encode immune evasion genes that complicate live virus vaccine design. …”
    Get full text
    Article
  8. 1048

    Newborn Mice Vaccination with BCG.HIVA222 + MVA.HIVA Enhances HIV-1-Specific Immune Responses: Influence of Age and Immunization Routes by Narcís Saubi, Eung-Jun Im, Raquel Fernández-Lloris, Olga Gil, Pere-Joan Cardona, Josep Maria Gatell, Tomáš Hanke, Joan Joseph

    Published 2011-01-01
    “…The frequencies of HIV-specific CD8+ T cells producing IFN-γ were higher in adult mice vaccinated intradermally and lower in adult and newborn mice vaccinated subcutaneously. …”
    Get full text
    Article
  9. 1049
  10. 1050
  11. 1051
  12. 1052
  13. 1053

    Low Seroconversion after One Dose of AS03-Adjuvanted H1N1 Pandemic Influenza Vaccine in Solid-Organ Transplant Recipients by Mariangela R Resende, Shahid Husain, Jonathan Gubbay, Lianne Singer, Edward Cole, Eberhard L Renner, Coleman Rotstein

    Published 2013-01-01
    “…As a result, solid-organ transplant (SOT) recipients were targeted as a priority group to receive AS03-adjuvanted H1N1 influenza vaccine during 2009.…”
    Get full text
    Article
  14. 1054
  15. 1055
  16. 1056
  17. 1057

    Protection Conferred by Gallid Alphaherpesvirus 2 Vaccines Against Immunosuppression Induced by Very Virulent Plus (vv+) Marek’s Disease Virus Strains in Commercial Meat Type Chickens by Nagwa Khaled, Carissa Gaghan, Abdelhamid M. Fares, Christa Goodell, William Stanley, Raveendra R. Kulkarni, Isabel M. Gimeno

    Published 2025-01-01
    “…We also demonstrated that the three vaccines protected against MDV-induced tumors, but only rMd5-BAC∆Meq and CVI-LTR protected against the negative impact of vv+MDV 648A strain on CEO vaccine efficacy. …”
    Get full text
    Article
  18. 1058
  19. 1059
  20. 1060